StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > FYI: Background and information for interested readers...

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Apr 14, 2021 10:22am

97 Views

Post# 32992243

RE:RE:RE:RE:FYI: Background and information for interested readers...

Get a room. I thought you sold why you crushing on gojotv.

cactuseskimo wrote:
Okay, you're right. The company never had a big change of direction. It was the stock price that did!

gojotv! wrote: The company never had a "big change of direction".
The idea that there was to be a takeover was speculation, and was never put out by management.
They said they would launch Aristotle, and they did.
They said they were going for the "employer" market, and they will.
They said they're going for FDA recognition in a year or two and they will. We don't have it yet, so the tests have to be done in-house. Those are the rules. That has always been the Law.
Anyone pretending to be surprised wasn't paying attention.
This is the way to go if we want to get Aristotle first to market, and not wait a couple of years and have to do a financing to get FDA approval.
It's all here under "Definition and Use of Laboratory Developed Tests":

https://www.ascp.org/content/docs/default-source/policy-statements/ascp-pdft-pp-regulation-of-ltds.pdf?sfvrsn=0

cactuseskimo wrote:
No bad news? No bad news!? The company does a big change of direction, pisses off their analysts, drops over 50%, and gets their target dropped from 4.00 to 1.25. But yeah, other than that, the news is all good!!!

Folks, I don't care if you're long or short, but for the love of saint pete, do your own DD and don't trust clowns like this guy.

gojotv! wrote: The bashers on this board will have you believe that there's been bad news about this company, but the opposite is true. Do your DD.
The crash in share price of two weeks ago began BEFORE news and financials were released.
in fact, bashers got VERY upset when the company didn't release until after market close, probably because it exposed their stock manipulation for what it was... a concerted effort by a small group of bashers represented by a slew of new aliases., and whose posts were so outrageously offensive, slanderous and/or untruthful that they were repeatedly banned. Notice who on this board is supplying you with information, and who is just here to bully, lie, harrass and attack those posters who are posting facts. That will tell you who to trust.
Now, watch as those posters drown THIS post out and bury it pages back before opening of the trading day with repeated, empty posts of theirs.
Those are the people you shouldn't trust.
There. Now you're up to speed
GLTA!